Table 4.

Other PAL-LIFE Group Recommendations to Stakeholder Groups for the Promotion of Palliative Care

No.	Recommendations
6	To international organizations: International organizations should encourage WHO Member States to develop policies and procedures to implement the WHA Resolution 67/19 as an integral part of their strategies and to implement the Agenda 2030 for Sustainable Development Goals, paying specific attention to the needs of children and older persons.
7	To the mass media: Mass media should be involved in creating a culture of understanding around advanced illness and the role of palliative care throughout the life course and as a component of UHC.
8	To philanthropic organizations and charities: Individuals and organizations involved in palliative care must engage, educate, and advocate for philanthropic organizations and charities to support palliative care development and implementation of services.
9	To pharmaceutical authorities: Morphine (preferably immediate release oral formulation) is the preferred medication for the treatment of moderate/severe cancer pain and palliative care and should be made available and accessible. No government should approve modified-release morphine, transdermal fentanyl patches, or slow release oxycodone without also guaranteeing widely available immediate-release oral morphine.
10	To patients and patient groups: Patients and patient groups could be of great help in developing and demanding a health literacy campaign for all patients with PC needs and their families to increase the knowledge and understanding of PC and its role in the decision-making process.
11	To spiritual care professionals: Religious institutions and spiritual care groups should work to include spiritual care—including ongoing assessment of spiritual distress and spiritual well-being—integrated into guidelines of care and as a component of routine palliative care provision.
12	To professional associations and societies other than Palliative Care: Nonpalliative care professional associations and societies should encourage human rights organizations to consider existing declarations and to implement strategies whose aim is advancing palliative care development worldwide within a human rights framework.
13	To pharmacists: Pharmacists should play an active role in palliative care teams by assessing the appropriateness of the medicines prescribed to patients, by ensuring timely dispensation, by educating the team members about pharmacological interactions, and by ensuring that patients and caregivers understand the prescribed regimen to ensure adherence to treatment.

PC, palliative care; UHC, Universal Health Coverage.